Recent Company News

• 11:40 PM ET Mar 29, 2026
  

  Sartorius Stedim Biotech upgraded to buy from neutral at Goldman Sachs (€165.00, 0.00)

• 04:31 AM ET Feb 03, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:14 AM ET Mar 17, 2026
  

  Sartorius Stedim Biotech sets new medium term targets at CMD: targets organic sales revenue growth of +9-12% per year in constant currencies (€160.15, 0.00)

• 12:57 AM ET Mar 06, 2026
  

  Sartorius Stedim Biotech upgraded to outperform from sector perform at RBC Capital Markets (€170.15, 0.00)

• 05:47 AM ET Feb 06, 2026
  

  Sartorius Stedim Biotech S.A. proposes €0.69/share dividend (€177.00, -4.40)

• 09:27 AM ET Feb 03, 2026
  

  Transcript Intelligence: Sartorius Stedim Biotech Q4 Earnings Guidance

• 09:27 AM ET Feb 03, 2026
  

  Transcript Intelligence: Sartorius Stedim Biotech Q4 Earnings Q&A

• 09:27 AM ET Feb 03, 2026
  

  Transcript Intelligence: Sartorius Stedim Biotech Q4 Earnings Themes